Shanghai JMT-Bio Inc.   Report issue

For profit Phase 2
Founded: Shanghai China (2012)

Organization Overview

First Clinical Trial
2017
NCT04689100
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Shanghai JMT-Bio Inc.